Scancell receives approval to expand ModiFY cancer trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to expand its ModiFY...
Source: proactiveinvestors.co.uk
Stay updated with breaking news from Professor Lindy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to expand its ModiFY...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer, has announced the expansion of its Modi-1 trial in combination with...